Channing Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Channing Capital Management's ELV Position: Q1 2026 in Review
Channing Capital Management increased its Elevance Health (ELV) stake by 6.5% in Q1 2026, buying an estimated $631K and bringing the position to 31,493 shares worth $9.22M. The position accounts for 0.24% of the portfolio, ranked #72.
Channing Capital Management first reported a position in ELV in Q1 2019 and has held it in 16 quarters since. The position peaked at $11.6M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Channing Capital Management held 31,493 shares of Elevance Health worth $9.22M as of Q1 2026.
- Channing Capital Management bought 1,919 Elevance Health shares in Q1 2026, an estimated $631K.
- Elevance Health made up 0.24% of Channing Capital Management's portfolio in Q1 2026, its #72 holding.
- Channing Capital Management first reported a position in Elevance Health in Q1 2019 and has held it in 16 quarters since.
- Channing Capital Management's Elevance Health position peaked at $11.6M in Q3 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Channing Capital Management's 13F filing for Q1 2026, filed 14 May 2026.